• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quantification of sarcomatoid differentiation in renal cell carcinoma on magnetic resonance imaging.磁共振成像对肾细胞癌中肉瘤样分化的定量分析。
Quant Imaging Med Surg. 2018 May;8(4):373-382. doi: 10.21037/qims.2018.04.09.
2
Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma.将肉瘤样分化百分比作为肾细胞癌的预后因素。
Clin Genitourin Cancer. 2015 Jun;13(3):225-30. doi: 10.1016/j.clgc.2014.12.001. Epub 2014 Dec 9.
3
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?剖析结果:对于伴有肉瘤样去分化的转移性肾细胞癌患者,是否应进行减瘤性肾切除术?
Front Oncol. 2021 Feb 10;10:627025. doi: 10.3389/fonc.2020.627025. eCollection 2020.
4
[Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].[伴有肉瘤样分化的肾细胞癌的临床病理特征及预后]
Zhonghua Zhong Liu Za Zhi. 2015 Nov;37(11):823-6.
5
FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.具有肉瘤样分化的肾细胞癌的 FDG PET/CT 和 CT 表现。
AJR Am J Roentgenol. 2020 Sep;215(3):645-651. doi: 10.2214/AJR.19.22467. Epub 2020 Jul 1.
6
Identification of sarcomatoid differentiation in renal cell carcinoma by machine learning on multiparametric MRI.基于多参数 MRI 的机器学习在肾细胞癌中识别肉瘤样分化。
Sci Rep. 2021 Feb 15;11(1):3785. doi: 10.1038/s41598-021-83271-4.
7
Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation.磁共振成像(MRI)有助于鉴别具有肉瘤样分化的肾细胞癌与无肉瘤样分化的肾细胞癌。
Abdom Radiol (NY). 2022 Jun;47(6):2168-2177. doi: 10.1007/s00261-022-03501-9. Epub 2022 Apr 5.
8
Diagnosis of Sarcomatoid Renal Cell Carcinoma With CT: Evaluation by Qualitative Imaging Features and Texture Analysis.CT 诊断肉瘤样肾细胞癌:定性成像特征与纹理分析评估。
AJR Am J Roentgenol. 2015 May;204(5):1013-23. doi: 10.2214/AJR.14.13279.
9
Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma.Ki-67指数和肉瘤样分化百分比是肉瘤样肾细胞癌的两个独立预后预测指标。
Cancer Manag Res. 2018 Nov 5;10:5339-5347. doi: 10.2147/CMAR.S176242. eCollection 2018.
10
Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.肉瘤样肾细胞癌患者的治疗方法、结局和预后评分的有效性:20 年单机构经验。
Clin Genitourin Cancer. 2018 Jun;16(3):e577-e586. doi: 10.1016/j.clgc.2017.12.005. Epub 2017 Dec 28.

引用本文的文献

1
Diagnostic and prognostic role of F-FDG PET/CT for sarcomatoid differentiation in renal cell carcinoma.F-FDG PET/CT在肾细胞癌肉瘤样分化中的诊断和预后作用
EJNMMI Res. 2025 Feb 19;15(1):11. doi: 10.1186/s13550-025-01206-w.
2
Sarcomatoid renal cell carcinoma: MRI features and their association with survival.肉瘤样肾细胞癌:MRI 特征及其与生存的关系。
Cancer Imaging. 2023 Feb 15;23(1):16. doi: 10.1186/s40644-023-00535-0.
3
Magnetic resonance imaging (MRI) helps differentiate renal cell carcinoma with sarcomatoid differentiation from renal cell carcinoma without sarcomatoid differentiation.磁共振成像(MRI)有助于鉴别具有肉瘤样分化的肾细胞癌与无肉瘤样分化的肾细胞癌。
Abdom Radiol (NY). 2022 Jun;47(6):2168-2177. doi: 10.1007/s00261-022-03501-9. Epub 2022 Apr 5.
4
Identification of sarcomatoid differentiation in renal cell carcinoma by machine learning on multiparametric MRI.基于多参数 MRI 的机器学习在肾细胞癌中识别肉瘤样分化。
Sci Rep. 2021 Feb 15;11(1):3785. doi: 10.1038/s41598-021-83271-4.
5
Sarcomatoid renal cell carcinoma: biology, natural history and management.肉瘤样肾细胞癌:生物学、自然史与治疗。
Nat Rev Urol. 2020 Dec;17(12):659-678. doi: 10.1038/s41585-020-00382-9. Epub 2020 Oct 13.
6
A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma.基于 CT 的影像组学方法在梭形细胞和透明细胞肾细胞癌鉴别诊断中的应用。
Biomed Res Int. 2020 Jul 24;2020:7103647. doi: 10.1155/2020/7103647. eCollection 2020.

本文引用的文献

1
Systemic Therapy for Metastatic Renal-Cell Carcinoma.转移性肾细胞癌的全身治疗
N Engl J Med. 2017 Jan 26;376(4):354-366. doi: 10.1056/NEJMra1601333.
2
Systemic therapy in metastatic renal cell carcinoma.转移性肾细胞癌的全身治疗
World J Urol. 2017 Feb;35(2):179-188. doi: 10.1007/s00345-016-1868-5. Epub 2016 Jun 9.
3
Review of renal cell carcinoma and its common subtypes in radiology.肾细胞癌及其常见亚型的放射学综述。
World J Radiol. 2016 May 28;8(5):484-500. doi: 10.4329/wjr.v8.i5.484.
4
MR Fingerprinting for Rapid Quantitative Abdominal Imaging.用于快速定量腹部成像的磁共振指纹技术
Radiology. 2016 Apr;279(1):278-86. doi: 10.1148/radiol.2016152037. Epub 2016 Jan 21.
5
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.肉瘤样成分百分比作为伴肉瘤样去分化肾细胞癌生存预后指标的研究
Urol Oncol. 2015 Oct;33(10):427.e17-23. doi: 10.1016/j.urolonc.2015.04.011. Epub 2015 May 23.
6
Diagnosis of Sarcomatoid Renal Cell Carcinoma With CT: Evaluation by Qualitative Imaging Features and Texture Analysis.CT 诊断肉瘤样肾细胞癌:定性成像特征与纹理分析评估。
AJR Am J Roentgenol. 2015 May;204(5):1013-23. doi: 10.2214/AJR.14.13279.
7
Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.转移性肉瘤样肾细胞癌患者的预后:国际转移性肾细胞癌数据库联盟的结果
Clin Genitourin Cancer. 2015 Apr;13(2):e79-85. doi: 10.1016/j.clgc.2014.08.011. Epub 2014 Sep 23.
8
MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types.磁共振成像用于鉴别具有肉瘤样成分的肾细胞癌与其他肾肿瘤类型。
Abdom Imaging. 2015 Jan;40(1):112-9. doi: 10.1007/s00261-014-0185-y.
9
A novel prognostic model for patients with sarcomatoid renal cell carcinoma.一种用于肉瘤样肾细胞癌患者的新型预后模型。
BJU Int. 2015 Mar;115(3):405-11. doi: 10.1111/bju.12781. Epub 2014 Oct 19.
10
Sarcomatoid renal cell carcinoma: clinical outcome and survival after treatment with sunitinib.肉瘤样肾细胞癌:舒尼替尼治疗后的临床结局与生存情况
Clin Genitourin Cancer. 2014 Aug;12(4):251-5. doi: 10.1016/j.clgc.2013.12.001. Epub 2013 Dec 27.

磁共振成像对肾细胞癌中肉瘤样分化的定量分析。

Quantification of sarcomatoid differentiation in renal cell carcinoma on magnetic resonance imaging.

作者信息

Jeong Daniel, Raghunand Natarajan, Hernando Diego, Poch Michael, Jeong Katherine, Eck Brendan, Dhillon Jasreman

机构信息

Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Department of Radiology, University of Wisconsin-Madison. Madison, WI, USA.

出版信息

Quant Imaging Med Surg. 2018 May;8(4):373-382. doi: 10.21037/qims.2018.04.09.

DOI:10.21037/qims.2018.04.09
PMID:29928602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5989092/
Abstract

BACKGROUND

Sarcomatoid differentiation in renal cell carcinoma (sRCC) is histologically characterized by anaplastic changes of renal cell carcinoma (RCC) subtypes, which has been associated with a poor prognosis. sRCC is managed more aggressively than RCC without sarcomatoid components, so pre-operative detection of sarcomatoid differentiation would significantly affect surgical management. The purpose of this study is to compare the quantification of sarcomatoid features in RCCs on pre-operative magnetic resonance imaging (MRI) to standard histological examination.

METHODS

Patients who had nephrectomy at our institution between 2000 and 2015 with pathology proven RCC and pre-operative contrast enhanced MRI abdominal scans were retrospectively reviewed. A custom MATLAB routine calculated the portion of each manually segmented whole tumor with MRI signal suggestive of sarcomatoid involvement based on prior research (MRI%SARC). The primary endpoint compared MRI%SARC to percent sarcomatoid involvement estimated by histological examination (HIST%SARC) using Pearson correlation and Bland Altman analysis.

RESULTS

A total of 17 patients with sRCC (10 males, age 60.3±11.1 years) and 17 consecutive control patients with clear cell RCC (ccRCC) without sarcomatoid components (10 males, age 64.5±7.6 years) were evaluated. Pearson correlation analysis revealed a strong association between MRI%SARC and HIST%SARC (r=0.782, P<0.001). Bland-Altman analysis demonstrated proportional bias, with a mean bias of 19.29 [95% confidence interval (CI): 9.79-28.79] and with 95% limits of agreement of -16.93 (95% CI: -33.38 to -0.48) to 55.51 (95% CI: 39.06-71.96), suggesting MRI%SARC underestimated values compared to HIST%SARC by 19%.

CONCLUSIONS

Multiparametric pre-operative MRI analysis to quantify sarcomatoid features in RCC correlates with standard histological examination but underestimates percent sarcomatoid involvement.

摘要

背景

肾细胞癌中的肉瘤样分化(sRCC)在组织学上的特征是肾细胞癌(RCC)亚型的间变改变,这与预后不良相关。与无肉瘤样成分的RCC相比,sRCC的治疗更为积极,因此术前检测肉瘤样分化会显著影响手术管理。本研究的目的是比较术前磁共振成像(MRI)上RCC中肉瘤样特征的量化与标准组织学检查结果。

方法

回顾性分析2000年至2015年间在本机构接受肾切除术且病理证实为RCC并术前行腹部增强MRI扫描的患者。根据先前的研究,使用自定义的MATLAB程序计算每个手动分割的整个肿瘤中具有提示肉瘤样累及的MRI信号的部分(MRI%SARC)。主要终点是使用Pearson相关性分析和Bland Altman分析,将MRI%SARC与组织学检查估计的肉瘤样累及百分比(HIST%SARC)进行比较。

结果

共评估了17例sRCC患者(10例男性,年龄60.3±11.1岁)和17例连续的无肉瘤样成分的透明细胞肾细胞癌(ccRCC)对照患者(10例男性,年龄64.5±7.6岁)。Pearson相关性分析显示MRI%SARC与HIST%SARC之间存在强相关性(r = 0.782,P < 0.001)。Bland - Altman分析显示存在比例偏差,平均偏差为19.29 [95%置信区间(CI):9.79 - 28.79],95%一致性界限为 - 16.93(95% CI: - 33.38至 - 0.48)至55.51(95% CI:39.06 - 71.96),表明与HIST%SARC相比,MRI%SARC低估了19%的值。

结论

用于量化RCC中肉瘤样特征的多参数术前MRI分析与标准组织学检查相关,但低估了肉瘤样累及百分比。